BSE filing, NSE: ICICIGI. Summary written from the filing by ALFA Finder's alert engine.
ICICI Lombard General Insurance Company Ltd: key numbers
- Share price
- ₹1,649.00
- Market cap
- ₹82,407 Cr
- Revenue (annual)
- ₹26,994 Cr
- Net profit (annual)
- ₹2,772 Cr
- P/E (TTM)
- 32.2×Sector 20.6×
- Promoter holding
- 51.28%+0.06% QoQ
- FII holding
- 18.34%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from ICICI Lombard General Insurance Company Ltd
All →ICICI Lombard General Insurance Company Other Announcement
ICICI Lombard informed exchanges that its RTA, KFin Technologies, will shift its corporate office effective 1 December 2026. RTA contact details and registered office remain unchanged.
ICICI Lombard General Insurance Company Employee Stock Options
ICICI Lombard allotted 3,956 equity shares on 3 November 2026 under two employee schemes. A Whole-time Director approved the allotment under delegated authority.
ICICI Lombard General Insurance Company Acquisition Worth ₹172 Cr
ICICI Lombard disclosed that it acquired Rs.172 Crore of State Bank of India shares on October 28, 2026, in its ordinary-course investment function. Its cumulative holding in SBI is now 0.02%.
- Value
- ₹172.0 Cr
- Execution
- Investment made in multiple tranches over a period of time
ICICI Lombard General Insurance Company Employee Stock Options
ICICI Lombard allotted 84,705 equity shares under its employee stock option and stock unit schemes on 26 October 2026. Shares rank pari-passu with existing equity.
ICICI Lombard General Insurance Company Other Announcement
ICICI Lombard issued a TDS communication for the interim dividend of ₹7.0 per share declared on October 14, 2026. Shareholders must complete the required tax documentation.
ICICI Lombard General Insurance Company Dividend
ICICI Lombard's board declared an interim dividend of ₹7 per equity share, payable by November 12, 2026. The record date is set for October 23, 2026.
Other product launch announcements
All →AstraZeneca Pharma India Product Launch
AstraZeneca Pharma India will launch Datverzo, Datopotamab Deruxtecan, in India in November 2026. The drug holds DCGI import and market permission for HR-positive, HER2-negative breast cancer.
Raama Finance Product Launch
Raama Finance launched 'Rupya Lelo', a digital lending platform offering instant personal loans, on October 6, 2026. The product is available only in India, and no loan amount or financial figure is disclosed.
Puravankara Product Launch
Puravankara will launch the residential project Purva Cityspire Phases 1, 2 and 3 in Ernakulam on 15 November 2026. The project is RERA-registered and is being developed by two wholly owned subsidiaries.
JBM Auto Product Launch
JBM Electric Vehicles launched the all-electric ECOLIFE e12 city bus at Singapore Urban Mobility Week 2026. It cites 20,000-bus annual capacity and a new Singapore APAC hub.
- electric bus manufacturing capacity
- 20000.0 buses per annum
Restaurant Brands Asia Product Launch
Burger King India launches a limited-edition Avengers: Doomsday Collection across nationwide restaurants. The menu features themed burgers, sides, and merchandise starting at ₹199.
Hero MotoCorp Product Launch
Hero MotoCorp unveiled new motorcycles at EICMA 2026 and started VIDA customer deliveries across Europe. The company also introduced Novus Labs, its future-mobility innovation hub.